Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 283-829-2
CAS number: 84731-70-4
Clinical signs and mortality
No treatment-related clinical signs or death were found during the
A slight but statistically significant decrease in weight gains was
observed in group T2 compared to those of the group V2. This was
considered to be due to chance as there were no associated clinical
Observation of application sites
Approximately 48 and 72 h after the start of the challenge
application (24 and 48 h from the patch removal) the skin reaction was
observed. The average skin reaction scores in the group T1, V1 , T2 and
V2 at 48 h were 0.0, 0.0, 2.85 and 0.0 respectively. The sensitisation
rates at the same time point were 0, 0, 100 and 0 & respectively. Thus,
the skin sensitivity of the test substance was considered weak (Grade 1)
while that of the positive control item was extreme (Grade V). The
average skin reaction scores in the group T1, V1, T2 and V2 at 72 hours
were 0.0, 0.0, 2.55 and 0.0 respectively. The sensitisation rates at the
same time point were 0, 0, 100, 0 %, respectively.
Control results and validity
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again